文献速递神经免疫

多发性硬化中白质需氧糖酵解增加

Increased White Matter Aerobic Glycolysis in Multiple Sclerosis.
PubMed 文献 · Ann Neurol · 2024-12-23

本研究采用FDG-PET与MRI联合测量脑葡萄糖与氧代谢率,比较12名健康对照、20名复发型MS和13名非复发型MS患者。发现新诊断MS患者正常表现白质葡萄糖利用增加、氧利用减少,提示糖酵解增加,且糖酵解增加与病程更长和残疾更高相关。

要点

  • 新诊断MS患者正常表现白质葡萄糖利用增加、氧利用减少,提示糖酵解增加。
  • 糖酵解增加在病程更长和残疾更高的患者中更明显。
  • 正常表现白质中糖酵解增加与微结构炎症证据无关。

核心结论

  • 白质糖酵解增加是多发性硬化脑代谢的突出特征,始于病程早期,随疾病持续时间增加,且在正常表现白质中独立于微结构炎症证据。
  • 优化代谢环境可能是减少进行性残疾的治疗的重要组成部分。

研究设计与样本

  • 本研究使用FDG-PET与MRI联合测量脑葡萄糖和氧代谢率,从而量化糖酵解。
  • 研究纳入12名健康对照、20名复发型MS患者和13名非复发型MS患者。
  • 复发型MS患者为初治,在高疗效疾病修饰治疗开始前后进行扫描。

主要发现

  • 在正常表现白质中,新诊断MS患者观察到葡萄糖利用增加和氧利用减少,与糖酵解增加一致。
  • 糖酵解增加在病程更长和残疾更高的患者中更明显。
  • 在新诊断患者中,不同治疗对葡萄糖利用有不同影响。
  • 病灶内高代谢与炎症明显相关,而正常表现白质中未发现这种关系。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Despite treatments which reduce relapses in multiple sclerosis (MS), many patients continue to experience progressive disability accumulation. MS is associated with metabolic disruptions and cerebral metabolic stress predisposes to tissue injury and possibly impaired remyelination. Additionally, myelin homeostasis is metabolically expensive and reliant on glycolysis. We investigated cerebral metabolic changes in MS and when in the disease course they occurred, and assessed their relationship with microstructural changes. METHODS: This study used combined fluorodeoxyglucose (FDG) positron emission tomography (PET) and magnetic resonance imaging (MRI) to measure cerebral metabolic rate of glucose and oxygen, thereby quantifying glycolysis. Twelve healthy controls, 20 patients with relapsing MS, and 13 patients with non-relapsing MS were studied. Relapsing patients with MS were treatment naïve and scanned pre- and post-initiation of high efficacy disease modifying therapy. RESULTS: In normal appearing white matter, we observed increased glucose utilization and reduced oxygen utilization in newly diagnosed MS, consistent with increased glycolysis. Increased glycolysis was greater in patients with a longer disease duration course and higher disability. Among newly diagnosed patients, different treatments had differential impacts on glucose utilization. Last, whereas hypermetabolism within lesions was clearly associated with inflammation, no such relationship was found within normal appearing white matter. INTERPRETATION: Increased white matter glycolysis is a prominent feature of cerebral metabolism in MS. It begins early in the disease course, increases with disease duration and is independent of microstructural evidence of inflammation in normal appearing white matter. Optimization of the metabolic environment may be an important component of therapies designed to reduce progressive disability. ANN NEUROL 2025;97:766-778.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Brier MR, Judge B, Ying C, et al. Increased White Matter Aerobic Glycolysis in Multiple Sclerosis. Ann Neurol. 2024. PMID: 39714123. doi:10.1002/ana.27165

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。